MGC Pharmaceuticals Limited (MXC.L) LSE

21.20

-0.8(-3.64%)

Updated at April 02, 2024 01:47PM

Currency In GBp

Valuation

Market Cap16.85M
Enterprise Value17.18M
P/E Ratio-0.06
PEG Ratio-0
Price/Sales Ratio5.44
Price/Book Ratio-0.17
Enterprise/Revenue8.24
Enterprise/EBITDA-1.37

Fiscal Year

Fiscal YearJune 30, 2023
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin-6.15
Operating Margin-4.57

Management Effectiveness

Return On Assets-2.09
Return On Equity26.6

Income Statement

Revenue3.39M
Revenue/Share1.15
Gross Profit1.29M
EBITDA-20.12M
Net Income-20.82M
Diluted EPS-7.07

Balance Sheet

Total Cash239,821
Total Cash/Share0.08
Total Debt575,139
Total Debt/Equity-1.32
Current Ratio0.19
Book Value Per Share-2.73

Price History

52-Week Change4,773.56
52-Week High600
52-Week Low13.1
Moving Average 50 Days20.06
Moving Average 200 Days78.63

Statistics

Average Volume27,425
Shares Outstanding43.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:1000
Last Split DateNovember 02, 2023